
“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
SF tech bus program could be stalled by environmental appeals
Coming Soon to America: Bitcoin ATMs
Bitcoin exchanges shut shop in India
A surprising map of the countries that are most and least welcoming to foreigners
U.S. Banks to Face $120 Billion Shortfall in Fed Crisis Plan
Gitmo defendant’s lawyers: CIA gave ‘Zero Dark Thirty’ makers more info than us
Jeep owners urged to update their cars after hackers take remote control
Fannie Mae record profit: How long until it pays back bailout money?
Hedge Fund Manager Blows $60M Of Clients’ Money in Three Weeks
Al Franken's Privacy Concerns About Faceprints
This Billionaire Has Put Half His Net Worth Into Gold
Yellen Concerned Fed Models Fail to Predict Price Moves
China Bitcoin Exchange Restores Deposit Facility
Swiss bank breaks negative deposit rates taboo
Last month, this senator wanted to ban Bitcoin. Now, he’s not so sure